JP7898514B2 - グアンファシン及びモノカルボン酸を含むグアンファシンの経皮投与のための経皮治療システム - Google Patents
グアンファシン及びモノカルボン酸を含むグアンファシンの経皮投与のための経皮治療システムInfo
- Publication number
- JP7898514B2 JP7898514B2 JP2024513358A JP2024513358A JP7898514B2 JP 7898514 B2 JP7898514 B2 JP 7898514B2 JP 2024513358 A JP2024513358 A JP 2024513358A JP 2024513358 A JP2024513358 A JP 2024513358A JP 7898514 B2 JP7898514 B2 JP 7898514B2
- Authority
- JP
- Japan
- Prior art keywords
- guanfacine
- silicone
- containing layer
- weight
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21193889 | 2021-08-30 | ||
| EP21193889.9 | 2021-08-30 | ||
| PCT/EP2022/073922 WO2023031103A1 (en) | 2021-08-30 | 2022-08-29 | Transdermal therapeutic system for the transdermal administration of guanfacine comprising guanfacine and a mono-carboxylic acid |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024532418A JP2024532418A (ja) | 2024-09-05 |
| JP2024532418A5 JP2024532418A5 (cg-RX-API-DMAC7.html) | 2024-12-27 |
| JP7898514B2 true JP7898514B2 (ja) | 2026-07-31 |
Family
ID=77563915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513358A Active JP7898514B2 (ja) | 2021-08-30 | 2022-08-29 | グアンファシン及びモノカルボン酸を含むグアンファシンの経皮投与のための経皮治療システム |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240374544A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4395749B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7898514B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN117897144A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3226214A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023031103A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117379398A (zh) * | 2023-11-29 | 2024-01-12 | 长沙晶易医药科技股份有限公司 | 一种胍法辛透皮贴剂及其制备方法 |
| WO2026158595A1 (zh) * | 2025-01-25 | 2026-07-30 | 湖南派格兰药业有限公司 | 一种化合物i贴剂组合物、化合物i贴剂及其制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012515720A (ja) | 2009-01-20 | 2012-07-12 | ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー− ユーシーエルエー メディカル センター | 向精神薬の働きを向上させるソルビン酸、安息香酸及びその誘導体 |
| WO2017038767A1 (ja) | 2015-08-29 | 2017-03-09 | 株式会社メドレックス | 経皮吸収組成物 |
| JP2020536878A (ja) | 2017-10-11 | 2020-12-17 | エルテーエス ローマン テラピー−ジステーメ アーゲー | シリコーンアクリルハイブリッドポリマーを含むグアンファシンの経皮投与のための経皮治療システム |
| JP2020536882A (ja) | 2017-10-11 | 2020-12-17 | エルテーエス ローマン テラピー−ジステーメ アーゲー | 少なくとも1種の添加剤を含むグアンファシンの経皮投与のための経皮治療システム |
| JP2021517569A (ja) | 2018-03-13 | 2021-07-26 | エルテーエス ローマン テラピー−ジステーメ アーゲー | シリコーンアクリルハイブリッドポリマーを含む、ブプレノルフィンの経皮投与のための経皮治療システム |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07145048A (ja) * | 1993-11-25 | 1995-06-06 | Sekisui Chem Co Ltd | 医療用貼付剤 |
| KR101432698B1 (ko) | 2006-06-06 | 2014-08-22 | 다우 코닝 코포레이션 | 실리콘 아크릴레이트 하이브리드 조성물 |
| RU2544702C2 (ru) | 2009-04-24 | 2015-03-20 | Хенкель Корпорейшн | Клеи на основе силикон-акрилового гибридного полимера |
| JP2013139554A (ja) | 2011-11-29 | 2013-07-18 | Dow Corning Corp | シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法 |
| KR102048682B1 (ko) | 2015-02-09 | 2019-11-27 | 다우 실리콘즈 코포레이션 | 다중상 실리콘 아크릴 하이브리드 점탄성 조성물 및 이의 제조 방법 |
-
2022
- 2022-08-29 US US18/686,139 patent/US20240374544A1/en active Pending
- 2022-08-29 EP EP22769279.5A patent/EP4395749B1/en active Active
- 2022-08-29 JP JP2024513358A patent/JP7898514B2/ja active Active
- 2022-08-29 CA CA3226214A patent/CA3226214A1/en active Pending
- 2022-08-29 CN CN202280059240.1A patent/CN117897144A/zh active Pending
- 2022-08-29 WO PCT/EP2022/073922 patent/WO2023031103A1/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012515720A (ja) | 2009-01-20 | 2012-07-12 | ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー− ユーシーエルエー メディカル センター | 向精神薬の働きを向上させるソルビン酸、安息香酸及びその誘導体 |
| WO2017038767A1 (ja) | 2015-08-29 | 2017-03-09 | 株式会社メドレックス | 経皮吸収組成物 |
| JP2020536878A (ja) | 2017-10-11 | 2020-12-17 | エルテーエス ローマン テラピー−ジステーメ アーゲー | シリコーンアクリルハイブリッドポリマーを含むグアンファシンの経皮投与のための経皮治療システム |
| JP2020536882A (ja) | 2017-10-11 | 2020-12-17 | エルテーエス ローマン テラピー−ジステーメ アーゲー | 少なくとも1種の添加剤を含むグアンファシンの経皮投与のための経皮治療システム |
| JP2021517569A (ja) | 2018-03-13 | 2021-07-26 | エルテーエス ローマン テラピー−ジステーメ アーゲー | シリコーンアクリルハイブリッドポリマーを含む、ブプレノルフィンの経皮投与のための経皮治療システム |
Non-Patent Citations (1)
| Title |
|---|
| OTA, T. et al.,Evaluating Guanfacine Hydrochloride in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adult Patients: Design, Development and Place in Therapy,Drug Design, Development and Therapy,2021年05月11日,Vol.15,pp.1965-1969,DOI: 10.2147/DDDT.S221126 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024532418A (ja) | 2024-09-05 |
| EP4395749B1 (en) | 2025-11-19 |
| EP4395749C0 (en) | 2025-11-19 |
| CA3226214A1 (en) | 2023-03-09 |
| EP4395749A1 (en) | 2024-07-10 |
| CN117897144A (zh) | 2024-04-16 |
| US20240374544A1 (en) | 2024-11-14 |
| WO2023031103A1 (en) | 2023-03-09 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241219 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20241219 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250908 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251014 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260107 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260414 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260707 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260721 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7898514 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |